Stocktoria
Alto Neuroscience, Inc. ANRO
NYSE · XNYS · stock · Pharmaceutical Preparations · website · IPO 2024-02-02
Chart by TradingView
2/9
Piotroski F — financial health
4.67
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Financials | |||
| Operating income | -$66.4M | -$68.6M | -$37.8M |
| Net income | -$63.2M | -$61.4M | -$36.3M |
| Operating cash flow | -$51.8M | -$47.4M | -$33.4M |
| Free cash flow | -$51.8M | -$49.5M | -$33.9M |
| Total assets | $184.7M | $177.5M | $86.6M |
| Total liabilities | $33.5M | $26.1M | $16.8M |
| Shareholders' equity | $151.1M | $151.5M | -$71.7M |
| Ratios | |||
| Return on assets | -34.2% | -34.6% | -41.9% |
| Return on equity | -41.8% | -40.6% | 50.7% |
| Debt / equity | 0.11× | 0.07× | -0.14× |
| Current ratio | 15.69 | 16.92 | 15.22 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 503,087 | $11.3M |
| RENAISSANCE TECHNOLOGIES LLC | 103,499 | $2.3M |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 4.67 (safe)
- Working capital / assets 0.901
- Retained earnings / assets -1.092
- EBIT / assets -0.359
- Equity / liabilities 4.505
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001999480 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.